These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11641030)

  • 1. The effect of low-dose erythromycin on whole gastrointestinal transit time of preterm infants.
    Costalos C; Gavrili V; Skouteri V; Gounaris A
    Early Hum Dev; 2001 Dec; 65(2):91-6. PubMed ID: 11641030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythromycin as a prokinetic agent in preterm infants.
    Costalos C; Gounaris A; Varhalama E; Kokori F; Alexiou N; Kolovou E
    J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):23-5. PubMed ID: 11753159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythromycin fails to improve feeding outcome in feeding-intolerant preterm infants.
    ElHennawy AA; Sparks JW; Armentrout D; Huseby V; Berseth CL
    J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):281-6. PubMed ID: 12960650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing enteral feeding in preterm infants with feeding intolerance: a randomized controlled study of low-dose erythromycin.
    Ng SC; Gomez JM; Rajadurai VS; Saw SM; Quak SH
    J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):554-8. PubMed ID: 14581796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trial of cisapride in preterm infants.
    McClure RJ; Kristensen JH; Grauaug A
    Arch Dis Child Fetal Neonatal Ed; 1999 May; 80(3):F174-7. PubMed ID: 10212076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants.
    Mansi Y; Abdelaziz N; Ezzeldin Z; Ibrahim R
    Neonatology; 2011; 100(3):290-4. PubMed ID: 21701222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral erythromycin for treatment of feeding intolerance in preterm infants: a preliminary report.
    Sekteera W; Nuntnarumit P; Supapannachart S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1177-82. PubMed ID: 12549792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oral erythromycin for treatment of feeding intolerance in preterm infants.
    Nuntnarumit P; Kiatchoosakun P; Tantiprapa W; Boonkasidecha S
    J Pediatr; 2006 May; 148(5):600-5. PubMed ID: 16737869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythromycin and feeding intolerance in premature infants: a randomized trial.
    Aly H; Abdel-Hady H; Khashaba M; El-Badry N
    J Perinatol; 2007 Jan; 27(1):39-43. PubMed ID: 17036029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants.
    Ng PC; So KW; Fung KS; Lee CH; Fok TF; Wong E; Wong W; Cheung KL; Cheng AF
    Arch Dis Child Fetal Neonatal Ed; 2001 May; 84(3):F177-82. PubMed ID: 11320044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin for feeding intolerance in preterm infants.
    Ng E; Shah V
    Cochrane Database Syst Rev; 2000; (2):CD001815. PubMed ID: 10796273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous low-dose erythromycin administration for infants with feeding intolerance.
    Nogami K; Nishikubo T; Minowa H; Uchida Y; Kamitsuji H; Takahashi Y
    Pediatr Int; 2001 Dec; 43(6):605-10. PubMed ID: 11737737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of a randomised controlled trial on immune effects of acidic and neutral oligosaccharides in the nutrition of preterm infants: carrot study.
    Westerbeek EA; van Elburg RM; van den Berg A; van den Berg J; Twisk JW; Fetter WP; Lafeber HN
    BMC Pediatr; 2008 Oct; 8():46. PubMed ID: 18947426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythromycin for feeding intolerance in preterm infants.
    Ng E; Shah V
    Cochrane Database Syst Rev; 2001; (2):CD001815. PubMed ID: 11406010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrolysed protein accelerates the gastrointestinal transport of formula in preterm infants.
    Mihatsch WA; Högel J; Pohlandt F
    Acta Paediatr; 2001 Feb; 90(2):196-8. PubMed ID: 11236051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled trial of low-dose erythromycin to promote feed tolerance in preterm infants.
    Oei J; Lui K
    Acta Paediatr; 2001 Aug; 90(8):904-8. PubMed ID: 11529540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin shortens orocaecal transit time in diabetic male subjects: a double-blind placebo-controlled study.
    Minocha A; Katragadda R; Rahal PS; Ries A
    Aliment Pharmacol Ther; 1995 Oct; 9(5):529-33. PubMed ID: 8580273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of erythromycin on gastric emptying, duodeno-caecal transit time, gastric and biliopancreatic secretion during continuous gastric infusion of a liquid diet in healthy volunteers.
    Landry C; Vidon N; Sogni P; Nepveux P; Chaumeil JC; Chauvin JP; Couturier D; Chaussade S
    Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):797-802. PubMed ID: 7496872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prebiotic oligosaccharides reduce stool viscosity and accelerate gastrointestinal transport in preterm infants.
    Mihatsch WA; Hoegel J; Pohlandt F
    Acta Paediatr; 2006 Jul; 95(7):843-8. PubMed ID: 16801182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of erythromycin on the oro-caecal transit time in man.
    Lehtola J; Jauhonen P; Kesäniemi A; Wikberg R; Gordin A
    Eur J Clin Pharmacol; 1990; 39(6):555-8. PubMed ID: 2095341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.